News
Rat NGAL ELISA launched
June 27 2008
AACC 2008 Annual Meeting, 27-31 July 2008, Washington DC,
June 09 2008
INTERLEC-23 11-16 July 2008, Scotland
June 04 2008
An important addition to our complement antibody collection: Anti-C5b-9 (human) antibody
May 27 2008
New tools for cancer research: Plasminogen Activation System anti-bodies
May 05 2008
Product launch - Anti-NGAL (monkey) antibody
April 10 2008
The Biomarker World Congress 2008, 19-21 May - Philadelphia, USA
April 10 2008
ISICEM, Brussels, Belgium 18-21 March 2008
March 04 2008
BioPorto at ToxExpo, Seattle, Washington 16-20 March 2008
February 13 2008
We are participating at Arab Health Congress the 28 - 31 Jan 2008 in Dubai
January 17 2008
Product launch - Anti-NGAL (monkey) antibody
April 10 2008 by Janus Guttesen
BioPorto Diagnostics is pleased to announce the release of a new anti-monkey NGAL monoclonal antibody for sale. The antibody is expected to find use in the area of pre-clinical studies and acute kidney injury research.
The new monoclonal antibody (ABS 038-23) is specific for the monkey NGAL and is selected specifically for the ability to form an ELISA sandwich pair with biotinylated HYB 211-02 as detection antibody.
The antibody pair is for research use only and can be used to assay early nephrotoxicity of pharmacological compound in monkeys on an ELISA platform.
With the launch of monkey NGAL antibodies, BioPorto Diagnostics NGAL portfolio now consists of ELISA kits and antibodies against human, rat and monkey NGAL. Our NGAL portfolio will be expanded with mouse, dog, and pig antibodies in the near future.
